Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce A Mueller

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2008
Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosingKevin M Sowinski, Stephanie J Magner, Aroonrut Lucksiri, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzerKevin M Sowinski, Aroonrut Lucksiri, Michael B Kays, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 21, 2009
Pharmacist leads primary care team to improve diabetes careHae Mi Choe, Steven J Bernstein, Bruce A Mueller, et al.
Pharmacotherapy|August 19, 2003
Linezolid clearance during continuous venovenous hemodiafiltration: a case reportMichael D Kraft, Deborah A Pasko, Daryl D DePestel, et al.
Blood Purification|July 1, 2010
Modeled dalbavancin transmembrane clearance during intermittent and continuous renal replacement therapiesA Mary Vilay, Krishna H Shah, Mariann D Churchwell, et al.
Journal of Clinical Pharmacology|May 11, 2018
A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement TherapySoo Min Jang, Katherine N Gharibian, Susan J Lewis, et al.
Blood Purification|October 4, 2024
Pharmacokinetic Research in Pediatric Extracorporeal Therapies: Current State and Future DirectionsGideon Stitt, Céline Thibault, Bruce A Mueller, et al.
Pharmacotherapy|December 5, 2012
Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenationRachel F Eyler, Michael Heung, Melissa Pleva, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2009
Single-dose daptomycin pharmacokinetics in chronic haemodialysis patientsNoha N Salama, Jonathan H Segal, Mariann D Churchwell, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2009
Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysisNoha N Salama, Jonathan H Segal, Mariann D Churchwell, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2008
Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosingKevin M Sowinski, Stephanie J Magner, Aroonrut Lucksiri, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzerKevin M Sowinski, Aroonrut Lucksiri, Michael B Kays, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 21, 2009
Pharmacist leads primary care team to improve diabetes careHae Mi Choe, Steven J Bernstein, Bruce A Mueller, et al.
Pharmacotherapy|August 19, 2003
Linezolid clearance during continuous venovenous hemodiafiltration: a case reportMichael D Kraft, Deborah A Pasko, Daryl D DePestel, et al.
Blood Purification|July 1, 2010
Modeled dalbavancin transmembrane clearance during intermittent and continuous renal replacement therapiesA Mary Vilay, Krishna H Shah, Mariann D Churchwell, et al.
Journal of Clinical Pharmacology|May 11, 2018
A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement TherapySoo Min Jang, Katherine N Gharibian, Susan J Lewis, et al.
Blood Purification|October 4, 2024
Pharmacokinetic Research in Pediatric Extracorporeal Therapies: Current State and Future DirectionsGideon Stitt, Céline Thibault, Bruce A Mueller, et al.
Pharmacotherapy|December 5, 2012
Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenationRachel F Eyler, Michael Heung, Melissa Pleva, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2009
Single-dose daptomycin pharmacokinetics in chronic haemodialysis patientsNoha N Salama, Jonathan H Segal, Mariann D Churchwell, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2009
Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysisNoha N Salama, Jonathan H Segal, Mariann D Churchwell, et al.
Pageof 10